CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST)
Home  ⇨  Test Types   ⇨   CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST)
CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST)

ITEM ID
Z869

Item Name
CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST)

DOCTOR SPECIALITY
Oncologist

DISEASE DESCRIPTION
Cancer

Test Status
Active

CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST)

Specimen

Submit Formalin fixed paraffin embedded Tissue Block. Ship at room temperature. Tissue block must contain at least 10% tumor tissue. Physician prescription is mandatory..

Method:

IHC, NGS

Report:

Sample submitted by 2nd day of the month. Report issued in 4 weeks.

Usage:

These biomarkers are used for better understanding of the kinetics and effectiveness of a drug. It detects early signals of efficacy for rapidly evaluating the impact of potential disease-modifying therapies.

Doctor Specialty:

Oncologist

Disease:

Cancer

Components::

*CD117 *DOG-1 *ERBB2 *KIT *BRAF *PDGFRA *TP53

Department:

PROFILES

Pre Test Information:

Tissue block must contain at least 10% tumor tissue. Physician Prescription is mandatory.